Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Comparison of PNF and Non-Immersive Virtual Reality-Assisted PNF Exercises in Individuals With Adhesive Capsulitis

11 de noviembre de 2026 actualizado por: Mehmet CANLI, Kirsehir Ahi Evran Universitesi

Comparison of the Effects of Proprioceptive Neuromuscular Facilitation Exercises and Non-Immersive Virtual Reality-Assisted Proprioceptive Neuromuscular Facilitation Exercises Added to Conventional Physiotherapy in Individuals With Adhesive Capsulitis: A Randomized Controlled Trial

his study aims to compare the effects of conventional physiotherapy combined with Proprioceptive Neuromuscular Facilitation (PNF) exercises and conventional physiotherapy combined with non-immersive virtual reality-assisted PNF exercises in individuals with adhesive capsulitis (frozen shoulder).

A total of 60 individuals aged 40-65 years who have been diagnosed with adhesive capsulitis will participate in this randomized controlled trial. Participants will be randomly assigned to one of two groups. The first group will receive conventional physiotherapy combined with traditional PNF exercises, while the second group will receive conventional physiotherapy combined with non-immersive virtual reality-assisted PNF exercises.

Both groups will receive treatment three times per week for six weeks, for a total of 18 sessions. Each session will last 60 minutes, including 45 minutes of conventional physiotherapy and 15 minutes of either traditional PNF exercises or virtual reality-assisted PNF exercises.

Participants will be evaluated before treatment and immediately after the six-week intervention. The assessments will examine pain intensity, pain catastrophizing, fear of movement (kinesiophobia), upper extremity function, and shoulder-specific pain and disability.

The study aims to determine whether non-immersive virtual reality-assisted PNF exercises provide additional benefits compared with traditional PNF exercises when combined with conventional physiotherapy in individuals with adhesive capsulitis.

Descripción general del estudio

Descripción detallada

Adhesive capsulitis is a musculoskeletal condition characterized by shoulder pain, progressive restriction of active and passive range of motion, and limitations in daily activities. Although conventional physiotherapy is commonly used to improve pain and shoulder function, additional rehabilitation approaches may provide further benefits.

Proprioceptive Neuromuscular Facilitation (PNF) is a therapeutic exercise approach involving spiral and diagonal movement patterns designed to improve neuromuscular control, coordination, and functional movement. Non-immersive virtual reality-assisted rehabilitation allows individuals to perform therapeutic movements in an interactive digital environment while receiving real-time visual feedback.

This study is designed as a two-arm, parallel-group, randomized controlled trial to investigate whether integrating non-immersive virtual reality into PNF exercises provides additional clinical and psychosocial benefits compared with traditional PNF exercises in individuals with adhesive capsulitis.

The interventions will incorporate upper extremity PNF diagonal movement patterns. In the traditional PNF group, these movements will be performed under the guidance of a physiotherapist using established PNF techniques. In the virtual reality-assisted PNF group, corresponding movement patterns will be performed through an interactive screen-based system that tracks upper extremity movements and provides real-time visual feedback.

The study will examine changes in pain intensity, pain catastrophizing, kinesiophobia, upper extremity function, and shoulder-specific pain and disability. Outcomes will be assessed using the Visual Analog Scale (VAS), Pain Catastrophizing Scale (PCS), Tampa Scale for Kinesiophobia (TSK), Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH), and Shoulder Pain and Disability Index (SPADI).

By comparing these approaches, the study seeks to determine the potential contribution of non-immersive virtual reality to PNF-based rehabilitation and provide evidence regarding its clinical applicability in individuals with adhesive capsulitis.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

40 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

Individuals aged 40-65 years.

Diagnosis of adhesive capsulitis confirmed by a specialist physician.

Restriction of both active and passive range of motion in the affected shoulder.

Significant limitation of shoulder external rotation compared with the contralateral side.

Ability to understand and follow verbal and visual instructions provided during the study.

Willingness to participate regularly in the six-week treatment program.

Voluntary participation in the study and provision of written informed consent.

Exclusion Criteria:

Presence of a full-thickness rotator cuff tear, advanced glenohumeral osteoarthritis, fracture, dislocation, or malignancy in the affected shoulder.

History of previous surgery involving the affected shoulder.

Cervical radiculopathy or other neurological disorders that may affect shoulder movements.

Presence of inflammatory rheumatic diseases.

Bilateral adhesive capsulitis.

History of injection therapy in the shoulder region within the previous three months.

Participation in another shoulder rehabilitation program during the study period.

Uncontrolled cardiovascular, neurological, or systemic diseases that may interfere with exercise participation.

Severe uncorrected visual impairment that prevents participants from viewing or following the non-immersive virtual reality application.

Cognitive impairment severe enough to interfere with communication or completion of assessment questionnaires.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Conventional Physiotherapy + Proprioceptive Neuromuscular Facilitation (PNF)

Participants in this group will receive conventional physiotherapy combined with traditional Proprioceptive Neuromuscular Facilitation (PNF) exercises. Each treatment session will last 60 minutes, consisting of 45 minutes of conventional physiotherapy and 15 minutes of therapist-guided PNF exercises. The PNF program will include upper extremity diagonal movement patterns (D1 and D2 flexion and extension). Treatment will be administered three times per week for six weeks, for a total of 18 sessions.

Participants will receive 45 minutes of conventional physiotherapy, including 15 minutes of superficial heat application, 15 minutes of transcutaneous electrical nerve stimulation (TENS), and 15 minutes of therapeutic exercises. Therapeutic exercises will include Codman pendulum exercises, active-assisted shoulder range of motion exercises, and stretching of the posterior shoulder capsule and pectoral muscles.

Following conventional physiotherapy, participants will perform 15 minutes of therapist-guided Proprioceptive Neuromuscular Facilitation (PNF) exercises involving upper extremity D1 and D2 flexion-extension diagonal patterns. Each diagonal pattern will be performed in two sets of 10 repetitions, with 30 seconds of rest between sets. Rhythmic initiation and progressive pain-free manual resistance will be applied according to individual tolerance.

Treatment will be administered three times per week for six weeks, totaling 18 sessions.

Experimental: Conventional Physiotherapy + Non-Immersive Virtual Reality-Assisted PNF

Participants in this group will receive conventional physiotherapy combined with non-immersive virtual reality-assisted Proprioceptive Neuromuscular Facilitation (PNF) exercises. Each treatment session will last 60 minutes, consisting of 45 minutes of conventional physiotherapy and 15 minutes of virtual reality-assisted PNF exercises. The exercises will involve upper extremity diagonal movement patterns (D1 and D2 flexion and extension) performed using a screen-based interactive system that provides real-time visual feedback. Treatment will be administered three times per week for six weeks, for a total of 18 sessions.

Participants will receive the same 45-minute conventional physiotherapy program, including 15 minutes of superficial heat application, 15 minutes of transcutaneous electrical nerve stimulation (TENS), and 15 minutes of therapeutic exercises consisting of Codman pendulum exercises, active-assisted shoulder range of motion exercises, and stretching exercises.

Following conventional physiotherapy, participants will perform 15 minutes of non-immersive virtual reality-assisted Proprioceptive Neuromuscular Facilitation (PNF) exercises. Upper extremity D1 and D2 flexion-extension diagonal movement patterns will be performed using a screen-based interactive virtual environment. A motion-tracking system will transfer upper extremity movements to virtual targets and provide real-time visual feedback regarding movement direction and completion.

Treatment will be administered three times per week for six weeks, totaling 18 sessions.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Shoulder Pain and Disability Index (SPADI) Total Score
Periodo de tiempo: 6 weeks

Shoulder-specific pain and disability will be assessed using the Shoulder Pain and Disability Index (SPADI). The SPADI consists of 13 items divided into two subscales: pain (5 items) and disability (8 items). Pain and disability subscale scores are calculated separately, and a total SPADI score is obtained. Scores range from 0 to 100, with higher scores indicating greater shoulder pain and functional disability. The primary outcome will be the change in the SPADI total score from baseline to the end of the six-week intervention.

6 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Pain Intensity Assessed by the Visual Analog Scale (VAS)
Periodo de tiempo: 6 weeks

Pain intensity will be assessed using the Visual Analog Scale (VAS) under three conditions: at rest, during activity, and at night. Participants will indicate their pain intensity experienced during the previous week on three separate 10-cm horizontal lines, ranging from 0 (no pain) to 10 (unbearable pain). The distance from the starting point to the marked position will be measured in centimeters. Higher scores indicate greater pain intensity. Changes in resting, activity-related, and nighttime pain will be evaluated separately from baseline to the end of the six-week intervention.

6 weeks
Change in Tampa Scale for Kinesiophobia (TSK) Total Score
Periodo de tiempo: 6 weeks

Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia (TSK), which measures fear of movement associated with pain or anticipated reinjury. The scale consists of 17 items, each scored from 1 (strongly disagree) to 4 (strongly agree). After reverse-scoring four items, the total score ranges from 17 to 68, with higher scores indicating greater fear of movement. Changes in the total TSK score will be assessed from baseline to the end of the six-week intervention.

6 weeks
Change in Disabilities of the Arm, Shoulder and Hand (DASH) Score
Periodo de tiempo: 6 week

Upper extremity function will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The DASH consists of 30 items evaluating difficulties in performing daily activities, limitations in social and occupational functioning, pain, and other upper extremity symptoms. Each item is scored from 1 to 5, and the total score is transformed to a scale ranging from 0 to 100. A score of 0 indicates no disability, while 100 indicates the greatest level of disability. Changes in the DASH score will be assessed from baseline to the end of the six-week intervention.

6 week
Change in Pain Catastrophizing Scale (PCS) Total Score
Periodo de tiempo: 6 weeks

Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS). The scale consists of 13 items divided into three subscales: rumination, magnification, and helplessness. Each item is scored from 0 (not at all) to 4 (all the time), resulting in a total score ranging from 0 to 52. Higher scores indicate greater levels of pain catastrophizing. Changes in the total PCS score will be assessed from baseline to the end of the six-week intervention.

6 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Mehmet CANLI, PhD., Kirsehir Ahi Evran Universitesi

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

15 de diciembre de 2026

Finalización primaria (Estimado)

1 de mayo de 2027

Finalización del estudio (Estimado)

15 de mayo de 2027

Fechas de registro del estudio

Enviado por primera vez

11 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Publicado por primera vez (Actual)

17 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 43834581758%

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir